← back to search

Keith Danahey

University of Chicago · US
Area of research
Pharmacology · Genetics
Research interest
Research interests include Pharmacogenetics and Drug Metabolism, Genomics and Rare Diseases, Pharmaceutical studies and practices, and BRCA gene mutations in cancer.
h-index
17
citations
1,059
works
40
NIH funding
primary concept
email

Recent publications

Implementation of pharmacogenomics into inpatient general medicine
Pharmacogenetics and Genomics 2022cited by 13position: middledoi
Impact of <i>CYP2D6</i> Pharmacogenomic Status on Pain Control Among <scp>Opioid-Treated</scp> Oncology Patients
The Oncologist 2021cited by 29position: middledoi
COVIDOSE: A Phase II Clinical Trial of Low‐Dose Tocilizumab in the Treatment of Noncritical COVID‐19 Pneumonia
Clinical Pharmacology & Therapeutics 2020cited by 59position: middledoi
Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial
Therapeutic Advances in Medical Oncology 2020cited by 21position: middledoi
Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study
Pharmacogenetics and Genomics 2018cited by 33position: middledoi
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology
Cancer 2018cited by 17position: middledoi
Pharmacogenomics‐Based Point‐of‐Care Clinical Decision Support Significantly Alters Drug Prescribing
Clinical Pharmacology & Therapeutics 2017cited by 88position: middledoi
Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system
Journal of Biomedical Informatics 2017cited by 49position: firstdoi
Disease–drug database for pharmacogenomic‐based prescribing
Clinical Pharmacology & Therapeutics 2016cited by 17position: middledoi
Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs
Mayo Clinic Proceedings 2015cited by 50position: middledoi
Adoption of a clinical pharmacogenomics implementation program during outpatient care–initial results of the University of Chicago “1,200 Patients Project”
American Journal of Medical Genetics Part C Seminars in Medical Genetics 2014cited by 128position: middledoi
The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics
Clinical Pharmacology & Therapeutics 2012cited by 179position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark J. Ratain · University of Chicago10 papers (2012–2022)Peter H. O’Donnell · University of Illinois Chicago9 papers (2012–2022)Xander M.R. van Wijk · University of California, San Francisco3 papers (2020–2022)Rita Nanda · University of Chicago3 papers (2018–2020)Brittany A. Borden · Dana-Farber Cancer Institute3 papers (2017–2018)Matthew J. Sorrentino · University of Chicago3 papers (2014–2018)Rebecca M. Wellmann · The University of Texas at Austin2 papers (2018–2018)Walter M. Stadler · Cancer Research UK2 papers (2018–2018)David Meltzer · University of Chicago2 papers (2018–2022)Michael Jacobs · University of Chicago2 papers (2014–2015)Jared Spitz · Inova Health System2 papers (2012–2015)Donald Saner · University of Chicago2 papers (2015–2017)Kiang-Teck J Yeo · University of Chicago2 papers (2020–2021)Tien M. Truong · University of South Florida2 papers (2020–2021)Don Saner · Banner Health2 papers (2012–2014)Shennin Yuen · University of Chicago2 papers (2014–2015)Sheena Hussain · Medical College and Hospital, Kolkata2 papers (2016–2017)Natalie Reizine · University of Illinois Chicago2 papers (2020–2021)Merisa Middlestadt · University of Chicago2 papers (2021–2022)PM Galecki · University of Chicago1 papers (2016–2016)